Synthesis and Evaluation of Hydrophilic Linkers for Antibody-Maytansinoid Conjugates

被引:147
|
作者
Zhao, Robert Y. [1 ]
Wilhelm, Sharon D. [1 ]
Audette, Charlene [1 ]
Jones, Gregory [1 ]
Leece, Barbara A. [1 ]
Lazar, Alexandru C. [1 ]
Goldmacher, Victor S. [1 ]
Singh, Rajeeva [1 ]
Kovtun, Yelena [1 ]
Widdison, Wayne C. [1 ]
Lambert, John M. [1 ]
Chari, Ravi V. J. [1 ]
机构
[1] ImmunoGen Inc, Waltham, MA 02451 USA
关键词
CALICHEAMICIN CONJUGATE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CANCER; CELLS; DOXORUBICIN; ACID; TRANSPORTERS; CHEMOTHERAPY; SPECIFICITY;
D O I
10.1021/jm2002958
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biological evaluation of hydrophilic heterobifunctional cross-linkers for conjugation of antibodies with highly cytotoxic agents are described. These linkers contain either a negatively charged sulfonate group or a hydrophilic, noncharged PEG group in addition to an amine-reactive N-hydroxysuccinimide (NHS) ester and sulfhydryl reactive termini. These hydrophilic linkers enable conjugation of hydrophobic organic molecule drugs, such as a maytansinoid, at a higher drug/antibody ratio (DAR) than hydrophobic SPDB and SMCC linkers used earlier without triggering aggregation or loss of affinity of the resulting conjugate. Antibody maytansinoid conjugates (AMCs) bearing these sulfonate- or PEG-containing hydrophilic linkers were, depending on the nature of the targeted cells, equally to more cytotoxic to antigen-positive cells and equally to less cytotoxic to antigen-negative cells than conjugates made with SPDB or SMCC linkers and thus typically displayed a wider selectivity window, particularly against multidrug resistant (MDR) cancer cell lines in vitro and tumor xenograft models in vivo.
引用
收藏
页码:3606 / 3623
页数:18
相关论文
共 50 条
  • [1] ADME of Antibody-Maytansinoid Conjugates
    Erickson, Hans K.
    Lambert, John M.
    AAPS JOURNAL, 2012, 14 (04): : 799 - 805
  • [2] Antibody-maytansinoid conjugates for the treatment of myeloma
    Lutz, Robert J.
    Whiteman, Kathleen R.
    MABS, 2009, 1 (06) : 548 - 551
  • [3] Metabolites of Antibody-Maytansinoid Conjugates: Characteristics and in Vitro Potencies
    Widdison, Wayne
    Wilhelm, Sharon
    Veale, Karen
    Costoplus, Juliet
    Jones, Gregory
    Audette, Charlene
    Leece, Barbara
    Bartle, Laura
    Kovtun, Yelena
    Chari, Ravi
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 1762 - 1773
  • [4] Design of Antibody-Maytansinoid Conjugates Allows for Efficient Detoxification via Liver Metabolism
    Sun, Xiuxia
    Widdison, Wayne
    Mayo, Michele
    Wilhelm, Sharon
    Leece, Barbara
    Chari, Ravi
    Singh, Rajeeva
    Erickson, Hans
    BIOCONJUGATE CHEMISTRY, 2011, 22 (04) : 728 - 735
  • [5] In Vitro Characterization of the Drug-Drug Interaction Potential of Catabolites of Antibody-Maytansinoid Conjugates
    Davis, John A.
    Rock, Dan A.
    Wienkers, Larry C.
    Pearson, Josh T.
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (10) : 1927 - 1934
  • [6] Structural Characterization of a Monoclonal Antibody-Maytansinoid Immunoconjugate
    Luo, Quanzhou
    Chung, Hyo Helen
    Borths, Christopher
    Janson, Matthew
    Wen, Jie
    Joubert, Marisa K.
    Wypych, Jette
    ANALYTICAL CHEMISTRY, 2016, 88 (01) : 695 - 702
  • [7] Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody-Maytansinoid Conjugates
    Erickson, Hans K.
    Widdison, Wayne C.
    Mayo, Michele F.
    Whiteman, Kathleen
    Audette, Charlene
    Wilhelm, Sharon D.
    Singh, Rajeeva
    BIOCONJUGATE CHEMISTRY, 2010, 21 (01) : 84 - 92
  • [8] ADME of Antibody–Maytansinoid Conjugates
    Hans K. Erickson
    John M. Lambert
    The AAPS Journal, 2012, 14 : 799 - 805
  • [9] Disulfide-Linked Antibody-Maytansinoid Conjugates: Optimization of In Vivo Activity by Varying the Steric Hindrance at Carbon Atoms Adjacent to the Disulfide Linkage
    Kellogg, Brenda A.
    Garrett, Lisa
    Kovtun, Yelena
    Lai, Katharine C.
    Leece, Barbara
    Miller, Michael
    Payne, Gillian
    Steeves, Rita
    Whiteman, Kathleen R.
    Widdison, Wayne
    Xie, Hongsheng
    Singh, Rajeeva
    Chari, Ravi V. J.
    Lambert, John M.
    Lutz, Robert J.
    BIOCONJUGATE CHEMISTRY, 2011, 22 (04) : 717 - 727
  • [10] Cleavable linkers in antibody-drug conjugates
    Bargh, Jonathan D.
    Isidro-Llobet, Albert
    Parker, Jeremy S.
    Spring, David R.
    CHEMICAL SOCIETY REVIEWS, 2019, 48 (16) : 4361 - 4374